579 related articles for article (PubMed ID: 28683937)
41. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
[TBL] [Abstract][Full Text] [Related]
42. The independent value of a direct stenting strategy on early and late clinical outcomes in patients undergoing elective percutaneous coronary intervention.
Sardi GL; Laynez-Carnicero A; Torguson R; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
Catheter Cardiovasc Interv; 2013 May; 81(6):949-56. PubMed ID: 22888029
[TBL] [Abstract][Full Text] [Related]
43. Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents.
Li XT; Sun H; Zhang DP; Xu L; Ni ZH; Xia K; Liu Y; Chi YH; He JF; Li WM; Wang HS; Wang LF; Yang XC
Coron Artery Dis; 2014 Aug; 25(5):405-11. PubMed ID: 24584031
[TBL] [Abstract][Full Text] [Related]
44. One Versus 2-stent Strategy for the Treatment of Bifurcation Lesions in the Context of a Coronary Chronic Total Occlusion. A Multicenter Registry.
Ojeda S; Azzalini L; Chavarría J; Serra A; Hidalgo F; Benincasa S; Gheorghe LL; Diletti R; Romero M; Bellini B; Gutiérrez A; Suárez de Lezo J; Mazuelos F; Segura J; Carlino M; Colombo A; Pan M
Rev Esp Cardiol (Engl Ed); 2018 Jun; 71(6):432-439. PubMed ID: 29128364
[TBL] [Abstract][Full Text] [Related]
45. Cath Lab Robotics: Paradigm Change in Interventional Cardiology?
Wegermann ZK; Swaminathan RV; Rao SV
Curr Cardiol Rep; 2019 Aug; 21(10):119. PubMed ID: 31473815
[TBL] [Abstract][Full Text] [Related]
46. Short- and long-term benefits of drug-eluting stents compared to bare metal stents even in treatment for large coronary arteries.
Yoshida T; Sakata K; Nitta Y; Taguchi T; Kaku B; Katsuda S; Shimojima M; Gamou T; Nakahashi T; Konno T; Kawashiri MA; Yamagishi M; Hayashi K
Heart Vessels; 2016 May; 31(5):635-42. PubMed ID: 25758470
[TBL] [Abstract][Full Text] [Related]
47. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
[No Abstract] [Full Text] [Related]
48. Incidence, feasibility and outcome of percutaneous coronary intervention after transcatheter aortic valve implantation with a self-expanding prosthesis. Results from a single center experience.
Allali A; El-Mawardy M; Schwarz B; Sato T; Geist V; Toelg R; Richardt G; Abdel-Wahab M
Cardiovasc Revasc Med; 2016 Sep; 17(6):391-8. PubMed ID: 27396607
[TBL] [Abstract][Full Text] [Related]
49. Impact of robotics and a suspended lead suit on physician radiation exposure during percutaneous coronary intervention.
Madder RD; VanOosterhout S; Mulder A; Elmore M; Campbell J; Borgman A; Parker J; Wohns D
Cardiovasc Revasc Med; 2017; 18(3):190-196. PubMed ID: 28041859
[TBL] [Abstract][Full Text] [Related]
50. Experience and complications associated with use of guide extension catheters in percutaneous coronary intervention.
Waterbury TM; Sorajja P; Bell MR; Lennon RJ; Mathew V; Singh M; Sandhu GS; Gulati R
Catheter Cardiovasc Interv; 2016 Dec; 88(7):1057-1065. PubMed ID: 26698371
[TBL] [Abstract][Full Text] [Related]
51. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
[TBL] [Abstract][Full Text] [Related]
52. Radiation exposure and contrast agent use related to radial versus femoral arterial access during percutaneous coronary intervention (PCI)-Results of the FERARI study.
Becher T; Behnes M; Ünsal M; Baumann S; El-Battrawy I; Fastner C; Kuschyk J; Papavassiliu T; Hoffmann U; Mashayekhi K; Borggrefe M; Akin I
Cardiovasc Revasc Med; 2016 Dec; 17(8):505-509. PubMed ID: 27350417
[TBL] [Abstract][Full Text] [Related]
53. Initial success rate of percutaneous coronary intervention for chronic total occlusion in a native coronary artery is decreased in patients who underwent previous coronary artery bypass graft surgery.
Teramoto T; Tsuchikane E; Matsuo H; Suzuki Y; Ito T; Ito T; Habara M; Nasu K; Kimura M; Kinoshita Y; Terashima M; Asakura Y; Matsubara T; Suzuki T
JACC Cardiovasc Interv; 2014 Jan; 7(1):39-46. PubMed ID: 24456717
[TBL] [Abstract][Full Text] [Related]
54. Magnetic positioning system in coronary angiography and percutaneous intervention: a feasibility and safety study.
Weisz G; Smilowitz NR; Moses JW; Rabbani LE; Collins MB; Herscovici A; Jeron A; Leon MB; Luchner A
Catheter Cardiovasc Interv; 2013 Dec; 82(7):1084-90. PubMed ID: 23592312
[TBL] [Abstract][Full Text] [Related]
55. Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: the EES-bifurcation study.
Kherada NI; Sartori S; Tomey MI; Mennuni MG; Meelu OA; Roy S; Mohanty BD; Baber U; Pyo R; Kovacic JC; Sweeny J; Moreno P; Krishnan P; Dangas GD; Mehran R; Sharma SK; Kini AS
Int J Cardiol; 2014 Jun; 174(1):13-7. PubMed ID: 24731975
[TBL] [Abstract][Full Text] [Related]
56. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
[TBL] [Abstract][Full Text] [Related]
57. Robotics in percutaneous cardiovascular interventions.
Pourdjabbar A; Ang L; Behnamfar O; Patel MP; Reeves RR; Campbell PT; Madder RD; Mahmud E
Expert Rev Cardiovasc Ther; 2017 Nov; 15(11):825-833. PubMed ID: 28914558
[TBL] [Abstract][Full Text] [Related]
58. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
59. The Effect of Sex and Anthropometry on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Complex Coronary Lesions.
Lee SY; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Yonsei Med J; 2017 Mar; 58(2):296-304. PubMed ID: 28120559
[TBL] [Abstract][Full Text] [Related]
60. Planned Robotic Chronic Total Occlusion Percutaneous Coronary Intervention: Feasibility Report.
Walters D; Patel M; Reeves R; Ang L; Al Khiami B; Mahmud E
J Invasive Cardiol; 2020 Jun; 32(6):201-205. PubMed ID: 32330119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
